UK markets closed

Olema Pharmaceuticals, Inc. (OLMA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.95+0.12 (+1.22%)
At close: 04:00PM EDT
9.52 -0.43 (-4.32%)
After hours: 07:14PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 556.35M
Enterprise value 296.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.19
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.84

Trading information

Stock price history

Beta (5Y monthly) 2.11
52-week change 383.24%
S&P500 52-week change 322.36%
52-week high 317.79
52-week low 34.60
50-day moving average 311.93
200-day moving average 312.13

Share statistics

Avg vol (3-month) 3823.11k
Avg vol (10-day) 3666.1k
Shares outstanding 555.91M
Implied shares outstanding 655.91M
Float 828.47M
% held by insiders 13.94%
% held by institutions 196.23%
Shares short (15 Apr 2024) 48.97M
Short ratio (15 Apr 2024) 48.87
Short % of float (15 Apr 2024) 421.49%
Short % of shares outstanding (15 Apr 2024) 416.05%
Shares short (prior month 15 Mar 2024) 45.06M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-26.64%
Return on equity (ttm)-42.82%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -104.58M
Net income avi to common (ttm)-96.66M
Diluted EPS (ttm)-2.14
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)261.81M
Total cash per share (mrq)4.68
Total debt (mrq)2.42M
Total debt/equity (mrq)0.95%
Current ratio (mrq)12.33
Book value per share (mrq)4.62

Cash flow statement

Operating cash flow (ttm)-83.73M
Levered free cash flow (ttm)-43.1M